{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:15:23Z","timestamp":1782897323177,"version":"3.54.5"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2019.01254","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T09:38:40Z","timestamp":1569922720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes"],"prefix":"10.3389","volume":"10","author":[{"given":"Michal","family":"Fiedorowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Choragiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schuettauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Wojtunik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Turski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhart","family":"Zrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rejdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Damiano","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"B1","first-page":"1050","article-title":"Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush.","volume":"14","author":"Agudo","year":"2008","journal-title":"Mol. Vis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4762","article-title":"Integrated bioinformatic changes and analysis of retina with time in diabetic rats.","volume":"6","author":"Cui","year":"2018","journal-title":"PeerJ"},{"key":"B3","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1007\/s12035-018-1003-2","article-title":"Kynurenic acid restores Nrf2 levels and prevents quinolinic acid-induced toxicity in rat striatal slices.","volume":"55","author":"Ferreira","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5114\/fn.2014.45570","article-title":"Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model.","volume":"52","author":"Fiedorowicz","year":"2014","journal-title":"Folia Neuropathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","article-title":"L-tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences.","volume":"112","author":"Fujigaki","year":"2017","journal-title":"Neuropharmacology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5048","article-title":"Pathway analysis identifies altered mitochondrial metabolism, neurotransmission, structural pathways and complement cascade in retina\/RPE\/choroid in chick model of form-deprivation myopia.","volume":"6","author":"Giummarra","year":"2018","journal-title":"PeerJ"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2012.08493.x","article-title":"Quinolinic acid: neurotoxicity.","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10633-017-9586-x","article-title":"Pigmented and albino rats differ in their responses to moderate, acute and reversible intraocular pressure elevation.","volume":"134","author":"Gurdita","year":"2017","journal-title":"Doc. Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/s0378-4347(00)83925-0","article-title":"Quantification of 3-hydroxykynurenine in brain byhigh- performance liquid chromatography and electrochemical detection.","volume":"428","author":"Heyes","year":"1988","journal-title":"J. Chromatogr."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/420747","article-title":"Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes.","volume":"2008","author":"Hruz","year":"2008","journal-title":"Adv. Bioinform."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1167\/iovs.17-21654","article-title":"Increased indoleamine 2,3-dioxygenase and quinolinic acid expression in microglia and muller cells of diabetic human and rodent retina.","volume":"58","author":"Hu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease.","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1167\/iovs.02-0187","article-title":"Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina.","volume":"44","author":"Manabe","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B16","first-page":"1173","article-title":"N-methyl-D-Aspartic acid suppresses akt activity through protein phosphatase in retinal ganglion cells.","volume":"11","author":"Nakazawa","year":"2005","journal-title":"Mol. Vis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010110","article-title":"Retinal cell degeneration in animal models.","volume":"17","author":"Niwa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2015.00116","article-title":"Kynurenine 3-monooxygenase: an influential mediator of neuropathology.","volume":"6","author":"Parrott","year":"2015","journal-title":"Front. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1007\/s12035-017-0749-2","article-title":"Kynurenic acid prevents cytoskeletal disorganization induced by quinolinic acid in mixed cultures of rat striatum.","volume":"55","author":"Pierozan","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2371895","article-title":"3-hydroxykynurenine and 3-hydroxyanthranilic acid enhance the toxicity induced by copper in rat astrocyte culture.","volume":"2017","author":"Ramirez-Ortega","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.visres.2003.11.003","article-title":"Age-dependent decrease of retinal kynurenate and kynurenine aminotransferases in DBA\/2J mice, a model of ocular hypertension.","volume":"44","author":"Rejdak","year":"","journal-title":"Vis. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.visres.2003.07.007","article-title":"Expression of kynurenine aminotransferases in the rat retina during development.","volume":"44","author":"Rejdak","year":"","journal-title":"Vis. Res."},{"key":"B25","first-page":"132","article-title":"Presence of L-kynurenine aminotransferase III in retinal ganglion cells and corpora amylacea in the human retina and optic nerve.","volume":"49","author":"Rejdak","year":"2011","journal-title":"Folia Neuropathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0042-6989(02)00682-x","article-title":"Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage.","volume":"43","author":"Rejdak","year":"","journal-title":"Vis. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s0042-6989(03)00233-5","article-title":"Ontogenic changes of kynurenine aminotransferase I activity and its expression in the chicken retina.","volume":"43","author":"Rejdak","year":"","journal-title":"Vis. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1097\/00001756-200112040-00014","article-title":"Presence of kynurenic acid and kynurenine aminotransferases in the inner retina.","volume":"12","author":"Rejdak","year":"2001","journal-title":"Neuroreport"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection.","volume":"23","author":"Sas","year":"2018","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0414-414","article-title":"The kynurenine pathway: a finger in every pie.","author":"Savitz","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B31","first-page":"4313","article-title":"Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors.","volume":"41","author":"Schuettauf","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00417-006-0531-z","article-title":"Alterations of amino acids and glutamate transport in the DBA\/2J mouse retina; possible clues to degeneration.","volume":"245","author":"Schuettauf","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1293\/tox.2015-2037","article-title":"Characteristics of structures and lesions of the eye in laboratory animals used in toxicity studies.","volume":"28","author":"Shibuya","year":"2015","journal-title":"J. Toxicol. Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3892\/etm.2012.619","article-title":"Evaluation of a partial optic nerve crush model in rats.","volume":"4","author":"Tan","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"B35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00417-010-1425-7","article-title":"Neuroprotection by acetoacetate and beta-hydroxybutyrate against NMDA-induced RGC damage in rat\u2013possible involvement of kynurenic acid.","volume":"248","author":"Thaler","year":"","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.exer.2009.10.013","article-title":"Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.","volume":"90","author":"Thaler","year":"","journal-title":"Exp. Eye Res."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02180.x","article-title":"Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.","volume":"89","author":"Thaler","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00417-012-2000-1","article-title":"Tempol protects against intravitreous indocyanine green-induced retinal damage in rats.","volume":"250","author":"Thaler","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B39","first-page":"2382","article-title":"Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats.","volume":"37","author":"Vorwerk","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12031-013-0017-5","article-title":"PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia\/macrophage status into an acquired deactivation subtype.","volume":"51","author":"Wada","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063467","article-title":"Gene expression changes under cyclic mechanical stretching in rat retinal glial (Muller) cells.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1471-4159.2000.0750081.x","article-title":"Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression.","volume":"75","author":"Wei","year":"2000","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: the janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions.","volume":"8","author":"Wirthgen","year":"2017","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0014-4886(91)90145-3","article-title":"Systemic kainic acid administration in rats: effects on kynurenic acid production in vitro and in vivo.","volume":"113","author":"Wu","year":"1991","journal-title":"Exp. Neurol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/molecules21101307","article-title":"miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Vis."},{"key":"B47","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.116.7.906","article-title":"Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve.","volume":"116","author":"Yoles","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02713680601090965","article-title":"Elevated concentrations of kynurenic acid, a tryptophan derivative, in dense nuclear cataracts.","volume":"32","author":"Zarnowski","year":"2007","journal-title":"Curr. Eye Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jchromb.2010.01.006","article-title":"Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography.","volume":"878","author":"Zhao","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.01254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T09:38:43Z","timestamp":1569922723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.01254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":49,"alternative-id":["10.3389\/fphys.2019.01254"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2019.01254","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"article-number":"1254"}}